Development of sarcoidosis following etanercept treatment: A report of three cases

Rheumatology International

Volumn 32, Issue 4, 2012, Pages 1049-1053

  Skoie, Inger Marie ^a   Wildhagen, Klaus ^a   Omdal, Roald ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytokines; Sarcoidosis; T regulatory cells; Tumor necrosis factor alpha inhibitors

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; CASE REPORT; CYTOKINE PRODUCTION; DRUG WITHDRAWAL; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LIVER BIOPSY; LIVER FUNCTION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOIDOSIS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860911032     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-009-1349-x     Document Type: Article

References (40)

1. Massara A, Cavazzini L, La Corte R, Trotta F (2009) Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum 2009 14 Jan [Epub ahead of print]
2. Daïen CI, Monnier A, Claudepierre P et al (2009) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 48(8):865-866
3. Josse S, Klemmer N, Moreno-Swirc S, Goëb V, Lequerré T, Vittecoq O (2009) InXiximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient. Jt Bone Spine 76(6):718-719
4. Metyas SK, Tadros RM, Arkfeld DG (2009) Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis. Rheumatol Int 29:437-439
5. Toussirot E, Pertuiset E, Kantelip B, Wendling D (2008) Sarcoidosis occurring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol 26:471-475 (Pubitemid 352003220)
6. González-López MA, Blanco R, González-Vela MC, Fernández- Llaca H, Rodríguez-Valverde V (2006) Development of sarcoidosis during etanercept therapy. Arthritis Rheum 55:817-820 (Pubitemid 44619198)
7. Ishiguro T, Takayanagi N, Kurashima K et al (2008) Development of sarcoidosis during etanercept therapy. Intern Med 47:1021-1025
8. Farah RE, Shay MD (2007) Pulmonary sarcoidosis associated with etanercept therapy. Pharmacotherapy 27:1446-1448 (Pubitemid 47530450)
9. Almodóvar R, Izquierdo M, Zarco P, Javier Quirós F, Mazzucchelli R, Steen B (2007) Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol 25:99-101 (Pubitemid 46477494)
10. Kudrin A, Chilvers ER, Ginawi A et al (2007) Sarcoid-like granulomatous disease following etanercept treatment for RA. J Rheumatol 34:648-649
11. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R (2007) Development of sarcoidosis in etanercepttreated rheumatoid arthritis patients. Clin Rheumatol 26:1969-1971 (Pubitemid 47516989)
12. O'Shea FD, Marras TK, Inman RD (2006) Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum 55:978-981 (Pubitemid 44917474)
13. Hashkes PJ, Shajrawi I (2003) Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol 21:645-646 (Pubitemid 37236461)
14. Phillips K, Weinblatt M (2005) Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum 53:618-620 (Pubitemid 41278929)
15. Vavricka SR, Wettstein T, Speich R, Gaspert A, Bachli EB (2003) Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy. Thorax 58:278-279 (Pubitemid 36308009)
16. Peno-Green L, Lluberas G, Kingsley T, Brantley S (2002) Lung injury linked to etanercept therapy. Chest 122:1858-1860 (Pubitemid 35366106)
17. Sturfelt G, Christensson B, Bynke G, Saxne T (2007) Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab. J Rheumatol 34:2313-2314 (Pubitemid 350076897)
18. Louie GH, Chitkara P, Ward MM (2008) Relapse of sarcoidosis upon treatment with etanercept. Ann Rheum Dis 67:896-898 (Pubitemid 351829400)
19. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620-4627 (Pubitemid 34441368)
20. Baughman RP, Drent M, Kavuru M, Sarcoidosis Investigators et al (2006) InXiximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795-802 (Pubitemid 44511661)
21. Rossman MD, Newman LS, Baughman RP et al (2006) A doubleblinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc DiVuse Lung Dis 23:201-208 (Pubitemid 47596315)
22. Utz JP, Limper AH, Kalra S et al (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124:177-185 (Pubitemid 36851350)
23. Baughman RP, Lower EE, Bradley DA, Raymond LA, Kaufman A (2005) Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest 128:47-1062
24. Sandborn WJ, Hanauer SB, Katz S et al (2001) Etanercept for active Crohn's disease: a randomized, double-blind, placebocontrolled trial. Gastroenterology 121:1088-1094 (Pubitemid 33022088)
25. Brown SJ, Abreu MT (2005) Antibodies to tumor necrosis factoralpha in the treatment of Crohn's disease. Curr Opin Drug Discov Dev 8:160-168 (Pubitemid 40348968)
26. Sands BE, Anderson FH, Bernstein CN et al (2004) InXiximab maintenance therapy for Wstulizing Crohn's disease. N Engl J Med 350:876-885 (Pubitemid 38252535)
27. Sandborn WJ, Hanauer S, Loftus EV Jr et al (2004) An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol 99:1984-1989 (Pubitemid 39421244)
28. Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098-1104
29. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261-1265 (Pubitemid 38608568)
30. Furst DE, Wallis R, Broder M, Beenhouwer DO (2006) Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum 36:159-167 (Pubitemid 44691882)
31. Wallis RS, Ehlers S (2005) Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 34:34-38
32. Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153-2165
33. Ziegenhagen MW, Müller-Quernheim J (2003) The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 253:18-30 (Pubitemid 36120994)
34. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE (2006) TNF downmodulates the function of human CD4+ CD25hi T-regulatory cells. Blood 108:253-261 (Pubitemid 43990636)
35. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277-285 (Pubitemid 39031247)
36. Idali F, Wahlström J, Müller-Suur C, Eklund A, Grunewald J (2008) Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol 152:127-137 (Pubitemid 351347561)
37. Saliu OY, Sofer C, Stein DS, Schwander SK, Wallis RS (2006) Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. J Infect Dis 194:486-492 (Pubitemid 44162660)
38. Ioannou Y, Isenberg DA (2000) Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43:1431-1442 (Pubitemid 30452458)
39. Doyle MK, Berggren R, Magnus JH (2006) Interferon-induced sarcoidosis. J Clin Rheumatol 12:241-248 (Pubitemid 44527044)
40. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249-2254 (Pubitemid 23344886)